Free Trial
NASDAQ:WBA

Walgreens Boots Alliance Q3 2025 Earnings Report

Walgreens Boots Alliance logo
$11.52 -0.04 (-0.35%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$11.50 -0.02 (-0.17%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Walgreens Boots Alliance EPS Results

Actual EPS
$0.38
Consensus EPS
$0.34
Beat/Miss
Beat by +$0.04
One Year Ago EPS
$0.63

Walgreens Boots Alliance Revenue Results

Actual Revenue
$38.99 billion
Expected Revenue
$36.72 billion
Beat/Miss
Beat by +$2.27 billion
YoY Revenue Growth
+7.20%

Walgreens Boots Alliance Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, June 26, 2025
Conference Call Time
7:00AM ET

Earnings Documents

Walgreens Boots Alliance Earnings Headlines

This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
See More Walgreens Boots Alliance Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Walgreens Boots Alliance? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Walgreens Boots Alliance and other key companies, straight to your email.

About Walgreens Boots Alliance

Walgreens Boots Alliance (NASDAQ:WBA) (NASDAQ: WBA) is a leading global pharmacy-led health and wellbeing company that operates through three primary segments: Retail Pharmacy USA, International Pharmacy Retail, and Pharmaceutical Wholesale. The company serves millions of customers daily by providing prescription filling, health and wellness products, beauty and personal care items, and a range of healthcare services. Leveraging its extensive retail footprint and digital platforms, Walgreens Boots Alliance aims to offer convenient access to care, both in physical stores and online, ensuring continuity in patient support and medication management.

Founded through the merger of Walgreens, established in 1901 by Charles R. Walgreen, and Alliance Boots, which traces its origins to John Boot’s pharmacy in Nottingham in 1849, the company brings together more than a century of retail and pharmaceutical expertise. Since the merger in 2014, Walgreens Boots Alliance has expanded its presence across the United States, Europe, Latin America, and the Asia-Pacific region. The company’s diversified operations include wholesale distribution to independent pharmacies, hospitals, and clinics, positioning it as a critical link in the global healthcare supply chain.

Walgreens Boots Alliance offers an array of products and services, including over-the-counter medicines, consumer health and beauty products, clinical services such as immunizations and health checks, and prescription delivery. The company has invested in digital innovations like telehealth consultations, mobile prescription ordering, and personalized health programs designed to improve patient adherence and outcomes. Additionally, strategic partnerships with healthcare providers and technology firms bolster its integrated care model.

Under the leadership of Executive Chairman Stefano Pessina and Chief Executive Officer Rosalind Brewer, Walgreens Boots Alliance continues to pursue growth through strategic alliances, cost efficiencies, and expansion of its healthcare services. With a commitment to community health and sustainability, the company focuses on enhancing patient experiences, reducing healthcare costs, and promoting responsible business practices across its global operations.

View Walgreens Boots Alliance Profile

More Earnings Resources from MarketBeat